Gilles Freyer

发表

Links Between Cyclosporin Exposure in Tissues and Graft-Versus-Host Disease in Pediatric Bone Marrow Transplantation: Analysis by a PBPK Model

Yves Bertrand, Michel Tod, Pascal Girard, 2010, Pharmaceutical Research.

A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers.

Benoît You, Michel Tod, Benjamin Ribba, 2011, European journal of cancer.

Contribution of modelling chemotherapy-induced hematological toxicity for clinical practice.

Brigitte Tranchand, Pascal Girard, P. Girard, 2007, Critical reviews in oncology/hematology.

Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients

Athanassios Iliadis, Jérôme Guitton, Dominique Barbolosi, 2016, Breast Cancer Research and Treatment.

Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy.

Michel Tod, Benjamin Ribba, Paul Perrin, 2008, Clinical biochemistry.

Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs

Emilie Henin, Catherine Rioufol, Claude Dussart, 2011, BMC Cancer.

Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy

Athanassios Iliadis, Joseph Ciccolini, Dominique Barbolosi, 2016, Clinical Pharmacokinetics.

[Dosage regimen optimization in cancer chemotherapy using a mathematical model].

Athanassios Iliadis, Joseph Ciccolini, Dominique Barbolosi, 2003, Bulletin du cancer.

Hypersensitivity to oxaliplatin: clinical features and risk factors

Catherine Rioufol, Florence Ranchon, Nicolas Vantard, 2014, BMC Pharmacology and Toxicology.

Pharmacodynamic Models for Discrete Data

Michel Tod, Pascal Girard, P. Girard, 2012, Clinical Pharmacokinetics.

Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model

Yves Bertrand, Michel Tod, Pascal Girard, 2010, Pharmaceutical Research.

[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation].

Brigitte Tranchand, Emilie Hénin, Pascal Girard, 2007, Therapie.